JAPANESE JOURNAL OF CLINICAL ONCOLOGY

JAPANESE JOURNAL OF CLINICAL ONCOLOGY

JPN J CLIN ONCOL
影响因子:2.2
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:JAPAN
出版社:Oxford University Press
发刊时间:1971
发刊频率:Monthly
收录数据库:SCIE/Scopus收录
ISSN:0368-2811

期刊介绍

Japanese Journal of Clinical Oncology is a multidisciplinary journal for clinical oncologists which strives to publish high quality manuscripts addressing medical oncology, clinical trials, radiology, surgery, basic research, and palliative care. The journal aims to contribute to the world"s scientific community with special attention to the area of clinical oncology and the Asian region.JJCO publishes various articles types including: ・Original Articles ・Case Reports ・Clinical Trial Notes ・Cancer Genetics Reports ・Epidemiology Notes ・Technical Notes ・Short Communications ・Letters to the Editors ・Solicited Reviews
日本临床肿瘤学杂志是临床肿瘤学家的多学科期刊,致力于出版高质量的手稿,涉及医学肿瘤学,临床试验,放射学,外科,基础研究和姑息治疗。该杂志旨在为世界科学界做出贡献,特别关注临床肿瘤学和亚洲地区。JJCO发表各种文章类型,包括: ・原始文章・病例报告・临床试验笔记・癌症遗传学报告・流行病学笔记technical技术笔记short简短通讯・致编辑的信・征求意见
年发文量 170
国人发稿量 10.9
国人发文占比 0.06%
自引率 -
平均录取率0
平均审稿周期 一般,3-8周
版面费 -
偏重研究方向 医学-肿瘤学
期刊官网 https://academic.oup.com/jjco
投稿链接 http://mc.manuscriptcentral.com/jjco

期刊高被引文献

Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset
来源期刊:Japanese Journal of Clinical OncologyDOI:10.1093/jjco/hyy179
Overview of current and future systemic therapy for metastatic renal cell carcinoma
来源期刊:Japanese Journal of Clinical OncologyDOI:10.1093/jjco/hyz013
Using ALBI score at the start of sorafenib treatment to predict regorafenib treatment candidates in patients with hepatocellular carcinoma
来源期刊:Japanese Journal of Clinical OncologyDOI:10.1093/jjco/hyy153
Cigarette smoking and cervical cancer risk: an evaluation based on a systematic review and meta-analysis among Japanese women
来源期刊:Japanese Journal of Clinical OncologyDOI:10.1093/jjco/hyy158
Controversies in relation to neck management in N0 early oral tongue cancer
来源期刊:Japanese Journal of Clinical OncologyDOI:10.1093/jjco/hyy196
New revisions and current issues in the eighth edition of the TNM classification for non-small cell lung cancer.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyy142
Practice patterns of surgery for advanced ovarian cancer: analysis from international surveys
来源期刊:Japanese Journal of Clinical OncologyDOI:10.1093/jjco/hyy175
A population-based cohort study to evaluate the effectiveness of lung cancer screening using low-dose CT in Hitachi city, Japan
来源期刊:Japanese Journal of Clinical OncologyDOI:10.1093/jjco/hyy185
A primary analysis of a multicenter, prospective, single-arm, confirmatory trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906
来源期刊:Japanese Journal of Clinical OncologyDOI:10.1093/jjco/hyy160
Efficacy of axitinib in patients with metastatic renal cell carcinoma refractory to nivolumab therapy.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz040
Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with Stage IV colorectal cancer
来源期刊:Japanese Journal of Clinical OncologyDOI:10.1093/jjco/hyz035
Biomarker discordance between primary breast cancer and bone or bone marrow metastases
来源期刊:Japanese Journal of Clinical OncologyDOI:10.1093/jjco/hyz018
The single-base-pair deletion, MSH2 c.2635-3delC affecting intron 15 splicing can be a cause of Lynch syndrome.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz031
CRYAB inhibits migration and invasion of bladder cancer cells through the PI3K/AKT and ERK pathways.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz172
How to optimize the therapeutic effect of free autogenous fibula graft and wrist arthroplasty for giant cell tumors of distal radius?
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz045
Early detection of bone metastases of hepatocellular carcinoma reduces bone fracture and paralysis.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz028
Identification of serum microRNAs predicting the response of esophageal squamous-cell carcinoma to nivolumab.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz146
A randomized controlled trial comparing primary tumour resection plus chemotherapy with chemotherapy alone in incurable stage IV colorectal cancer: JCOG1007 (iPACS study)
来源期刊:Japanese Journal of Clinical OncologyDOI:10.1093/jjco/hyz173
Multicenter experience with large panel next-generation sequencing in patients with advanced solid cancers in Japan
来源期刊:Japanese Journal of Clinical OncologyDOI:10.1093/jjco/hyy173
Prognostic value of risk stratification using blood parameters for nivolumab in Japanese patients with metastatic renal-cell carcinoma.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz168
Surgical-related risk factors associated with anastomotic leakage after resection for rectal cancer: a meta-analysis.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz139
Efficacy and safety of pemetrexed plus cisplatin as first-line chemotherapy in advanced malignant peritoneal mesothelioma.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz104
Safety of central compartment neck dissection for transoral endoscopic thyroid surgery in papillary thyroid carcinoma.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz195
Risk factor for wound complications following wide resection of soft tissue sarcoma in the adductor compartment of the thigh.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz101
Acute kidney injury after platinum-based transcatheter arterial chemoembolization and transarterial infusion chemotherapy in patients with hepatocellular carcinoma.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz129
The road map of cancer precision medicine with the innovation of advanced cancer detection technology and personalized immunotherapy.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz073
Problems, goals and solutions reported by cancer patients participating in group problem-solving therapy
来源期刊:Japanese Journal of Clinical OncologyDOI:10.1093/jjco/hyy191
Prevalence and clinical implications of t(11;14) in patients with amyloid light-chain amyloidosis with or without concurrent multiple myeloma
来源期刊:Japanese Journal of Clinical OncologyDOI:10.1093/jjco/hyy202
Risk factors for acute exacerbation of idiopathic interstitial pneumonia in patients undergoing lung cancer treatment.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz115
Effect of neoadjuvant chemotherapy in patients undergoing radical cystectomy for muscle-invasive bladder cancer: a retrospective, multi-institutional study.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz137
Prostate-specific antigen response patterns during cabazitaxel therapy in patients with metastatic castration-resistant prostate cancer.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz110
Comparison of enteral nutrition with total parenteral nutrition for patients with locally advanced unresectable esophageal cancer harboring dysphagia in definitive chemoradiotherapy.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz089
Genomic based analyses reveal unique mutational profiling and identify prognostic biomarker for overall survival in Chinese small-cell lung cancer.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz131
Efficacy and safety of TC dose-dense chemotherapy as first-line treatment of epithelial ovarian cancer: a single-institution retrospective cohort study
来源期刊:Japanese Journal of Clinical OncologyDOI:10.1093/jjco/hyz011
Attitude of Japanese palliative care specialists towards adjuvant analgesics cancer-related neuropathic pain refractory to opioid therapy: a nationwide cross-sectional survey
来源期刊:Japanese Journal of Clinical OncologyDOI:10.1093/jjco/hyz002
Issues associated with medical tourism for cancer care in Japan.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/JJCO/HYZ061
Prognostic impact of TP53INP1 gene expression in estrogen receptor α-positive breast cancer patients.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz029
Mesenchymal-epithelial transition gene amplification and protein overexpression in stage IV pulmonary adenocarcinoma.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/JJCO/HYZ060
Outcome of maintenance systemic chemotherapy with drug-free interval for metastatic urothelial carcinoma
来源期刊:Japanese Journal of Clinical OncologyDOI:10.1093/jjco/hyz084
Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapy.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz067
A preliminary report of head-to-head comparison of 18-gene-based clinical-genomic model and oncotype DX 21-gene assay for predicting recurrence of early-stage breast cancer
来源期刊:Japanese Journal of Clinical OncologyDOI:10.1093/jjco/hyz102
Curative thoraco-systemic therapy plus local treatment to the brain for extensive disease-small-cell lung cancer with metastasis only to the brain.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz079
Nutritional support dependence after curative chemoradiotherapy in head and neck cancer: supplementary analysis of a phase II trial (JCOG0706S1).
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz121
Effectiveness of rapid titration with intravenous administration of oxycodone injection in advanced cancer patients with severe pain.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz145
Relationship between anastomotic leakage and CT value of the mesorectum in laparoscopic anterior resection for rectal cancer.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz192
Post-marketing observational study of everolimus in patients with unresectable or metastatic renal cell carcinoma in Japan.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz081
Revised staging system for malignant lymphoma based on the Lugano classification.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz111
Current approaches and future perspectives for advanced-stage follicular lymphoma with a low tumor burden
来源期刊:Japanese Journal of Clinical OncologyDOI:10.1093/jjco/hyz008
Efficiency and safety of TachoSil® in the treatment of postoperative air leakage following pulmonary surgery: a meta-analysis of randomized controlled trials.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz076
NLRP7 and KHDC3L variants in Chinese patients with recurrent hydatidiform moles.
来源期刊:Japanese journal of clinical oncologyDOI:10.1093/jjco/hyz036

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
89.41%23.02%-2.56%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q3区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
ONCOLOGY
Q3

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学4区
ONCOLOGY 肿瘤学
4区
2023年12月升级版
医学4区
ONCOLOGY 肿瘤学
4区
2022年12月旧的升级版
医学4区
ONCOLOGY 肿瘤学
4区